Docket Number:13A-880510
Inventor:Hung Li, Hsiu-Mei Hsieh-Li, Jan-Gowth Chang
IP Status:Issued US6,245,963
Abstract:
Homozygous mutation of the telomeric SMN (SMNT) gene in humans is associated with proximal spinal muscular atrophy (SMA), a severe motor neuron disease leading to muscle weakness with an onset predominantly in infancy and childhood. To further understand the functional role of the SMN gene in SMA, we produced mouse lines carrying a knockout mutation of the mouse Smn gene and transgenic mouse lines that expressed the human centromeric SMN (SMNC_ gene. Mice with the homozygous Smn knockout mutation died during the peri-implantation stage. Transgenic mice harboring the human SMNC with the Smn gene knockout showed pathological changes in spinal cord and skeletal muscle similar to SMA patients. The knockout-transgenic mice clearly demonstrated that the SMNT gene is responsible for SMA and should be useful in elucidating the molecular mechanisms of the SMN gene and in the design of therapeutic protocols for SMA patients.
Fields of Application:
Drug Discovery
Advantages when compared to the existing technologies:
A mouse model for spinal muscular atrophy(SMA). The second most common fatal autosomal recessive disease. This mouse model is deposited at Jackson Laboratory in US.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
